These findings suggest that the effects of MMA—increased LOXL2+ PSC infiltration and enhanced linear ECM alignment—not only contribute to short-term tumor progression but also correlate with long-term poor prognosis in PDAC patients. This evidence concerns the gene LOXL2 and neoplasm.